Clin2
NCT06967857Possibly a fitRecruiting

Dexamfetamine for adults with ADHD and depression

Attention-Deficit/Hyperactivity Disorder (ADHD)Depression - Major Depressive Disorder

Part of Mental health clinical trials.

This trial tests a study medication (dexamfetamine) for adults who have both ADHD and moderate to severe depression. It aims to see if the medication is safe and helps improve both conditions.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
105 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You must be 18 to 65 years old
  • You must have been diagnosed with ADHD since childhood (before age 12)
  • You must have moderate to severe depression that is not controlled by current treatment
  • You must be currently taking a stable dose of certain antidepressants (SSRIs or SNRIs) for at least 2 weeks
  • You must be willing to stop any current ADHD medications during the study
  • You cannot have serious heart problems, a history of seizures, or certain other medical conditions

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07086313Recruiting· Phase 2/Phase 3
Testing a new ADHD drug for children

This trial tests an experimental drug (EB-1020) for children with ADHD. It aims to see if the drug is safe and effective in reducing ADHD symptoms.

Sapporo
NCT06853665Recruiting· Phase 4
Study of mixed amphetamine for autism and ADHD in teens

This trial tests if a mixed amphetamine medication helps teenagers with both autism and ADHD who still have significant symptoms, even if they are already on other treatments. It also includes typically developing teens as a comparison group.

Boston, Massachusetts
NCT07843927Recruiting· Phase 3
Adding DHEA hormone to antidepressants for difficult depression

This study tests whether adding a natural hormone called DHEA to your regular antidepressant can help improve depression symptoms. DHEA is a supplement that may boost the effectiveness of standard antidepressants for people with hard-to-treat depression.

Berlin, State of Berlin
NCT07523048Recruiting· Phase 2
Dextromethorphan-Bupropion for Moderate-to-Severe Depression

This study tests a combination medication (dextromethorphan plus bupropion) to see how it affects brain activity in people with moderate-to-severe depression. Researchers use brain imaging (fMRI) to understand how the drug works and whether it may help relieve depression symptoms.

Toronto, Ontario
NCT06958692Recruiting· Phase 3
Testing a new antidepressant combination for depression

This study tests a new combination of two medications (dextromethorphan and bupropion) as a treatment for major depressive disorder. It may be an option if you have not already tried many antidepressants that didn't work.

Beijing, Beijing Municipality
NCT06248229Recruiting· Phase 4
Testing Dyanavel XR for fatigue in adults with ADHD

This trial tests whether the medication Dyanavel XR (a long-acting amphetamine) can help reduce fatigue in adults with ADHD. It is for people who have both ADHD and significant tiredness, and who are not currently taking stimulant ADHD drugs.

Rochester Hills, Michigan

Hear when a new Depression - Major Depressive Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.